【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Economic burden
• Types of lung cancer
• Diagnosis
• Staging of SCLC
• Staging of NSCLC
• Key buying criteria
PART 06: Pipeline analysis
PART 07: Market landscape
• Global lung cancer therapeutics market
• Five forces analysis
PART 08: Market segmentation by disease type
• NSCLC
• Global NSCLC market overview
• SCLC
• Global SCLC market overview
PART 09: Market segmentation by type of molecule
• Small molecules
• Biologics
PART 10: Geographical segmentation
• Lung cancer therapeutics market in Americas
• Lung cancer therapeutics market in EMEA
• Lung cancer therapeutics market in APAC
PART 11: Market drivers
• Growing demand for targeted therapies
• Presence of blockbuster drugs coupled with longer patent exclusivities
• Advancements in identification of molecular biomarkers increasing patient pool
• Paradigm shifts toward the adoption of checkpoint inhibitors
PART 12: Impact of drivers
PART 13: Market challenges
• Growing popularity of alternative therapeutics
• High costs leading to low adoption rate
• Adverse effects of drugs
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Emergence of nanomedicine platform for the treatment of lung cancer
• Advent of miRNA therapeutics in the treatment of lung cancer
• Growing strategic alliances for late-stage pipeline
• Growing approvals in lung cancer therapeutics market
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments of global lung cancer therapeutics market
Exhibit 03: Snapshot of lung cancer
Exhibit 04: Types of lung cancer
Exhibit 05: Main diagnostic procedures to determine presence of lung cancer
Exhibit 06: Staging of SCLC
Exhibit 07: Illustration of stages of NSCLC disease
Exhibit 08: Key buying criteria for lung cancer therapeutics
Exhibit 09: Factors affecting adoption rates of lung cancer therapeutics
Exhibit 10: Pipeline analysis of key vendors in global lung cancer therapeutics market
Exhibit 11: Percentage share of drug candidates by stage of development
Exhibit 12: Phase III pipeline portfolio: Global lung cancer therapeutics market
Exhibit 13: Phase II pipeline portfolio: Global lung cancer therapeutics market
Exhibit 14: Phase I pipeline portfolio: Global lung cancer therapeutics market
Exhibit 15: Global lung cancer therapeutics market snapshot
Exhibit 16: Analysis of global lung cancer therapeutics market
Exhibit 17: Global lung cancer therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 18: Opportunity analysis of global lung cancer therapeutics market
Exhibit 19: Opportunity analysis in developed and emerging markets
Exhibit 20: Five forces analysis
Exhibit 21: Segmentation of global lung cancer therapeutics market by disease type 2015 and 2020
Exhibit 22: Life cycle analysis of key segments in global lung cancer therapeutics market 2015
Exhibit 23: Types of NSCLC
Exhibit 24: Potential drugs/drug candidates in global NSCLC therapeutics market
Exhibit 25: Key drivers impacting market growth in NSCLC
Exhibit 26: Global NSCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 27: Opportunity analysis in global NSCLC market
Exhibit 28: Key points in SCLC
Exhibit 29: Key drivers impacting market growth in SCLC
Exhibit 30: Global SCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 31: Opportunity analysis in global SCLC therapeutics market
Exhibit 32: Segmentation of global lung cancer therapeutics market by type of molecule 2015
Exhibit 33: Global lung cancer therapeutics market by geographical segmentation 2015-2020
Exhibit 34: Segmentation of global lung therapeutics market based on geography 2015 and 2020
Exhibit 35: Lung cancer therapeutics market revenue by geography 2015-2020 ($ billions)
Exhibit 36: Lung cancer therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 37: Key trends across various countries in Americas
Exhibit 38: Lung cancer therapeutics market size and forecast in EMEA 2015-2020 ($ billions)
Exhibit 39: Drivers in lung cancer therapeutics market in EMEA
Exhibit 40: Key strategic initiatives in various countries in EMEA
Exhibit 41: Lung cancer therapeutics market size and forecast in APAC 2015-2020 ($ billions)
Exhibit 42: Key drivers and challenges in APAC
Exhibit 43: YoY growth rate of Avastin 2015
Exhibit 44: Performance of blockbuster drugs in 2015
Exhibit 45: Patent exclusivities of few blockbuster drugs
Exhibit 46: Recent launches of checkpoint inhibitors
Exhibit 47: Impact of drivers
Exhibit 48: Alternative therapies for lung cancer therapeutics
Exhibit 49: Costs of few lung cancer drugs ($)
Exhibit 50: Force field analysis of drivers and challenges in global lung cancer therapeutics market
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Trend analysis in global lung cancer therapeutics market
Exhibit 53: Key factors driving adoption of nanomedicine
Exhibit 54: Factors driving adoption of miRNA therapeutics
Exhibit 55: Key deals in global lung cancer therapeutics market
Exhibit 56: Recent approvals of lung cancer therapeutics
Exhibit 57: Competitive analysis in global lung cancer therapeutics market
Exhibit 58: Market penetration of various lung cancer therapeutics manufacturers in global (2015)
Exhibit 59: Regional analysis of vendors in global lung cancer therapeutics market
Exhibit 60: Vendors ranking in global lung cancer therapeutics market
Exhibit 61: F. Hoffmann-La Roche: Key highlights
Exhibit 62: F. Hoffmann-La Roche: Strength assessment
Exhibit 63: F. Hoffmann-La Roche: Strategy assessment
Exhibit 64: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 68: F. Hoffmann-La Roche: Geographic segmentation of Tarceva by revenue 2015
Exhibit 69: Eli Lilly: Key highlights
Exhibit 70: Eli Lilly: Strength assessment
Exhibit 71: Eli Lilly: Strategy assessment
Exhibit 72: Eli Lilly: Opportunity assessment
Exhibit 73: Eli Lilly: YoY revenue and growth rate of Alimta 2013-2015 ($ billions)
Exhibit 74: Eli Lilly: Geographic segmentation by revenue of Alimta 2015
Exhibit 75: Eli Lilly: YoY and growth rate of Cyramza 2014-2015 ($ millions)
Exhibit 76: Eli Lilly: Geographic segmentation by revenue of Cyramza 2015
Exhibit 77: AstraZeneca: Key highlights
Exhibit 78: AstraZeneca: Strength assessment
Exhibit 79: AstraZeneca: Strategy assessment
Exhibit 80: AstraZeneca: Opportunity assessment
Exhibit 81: AstraZeneca: YoY revenue and growth rate of Iressa 2013-2015 ($ billions)
Exhibit 82: AstraZeneca: Geographic segmentation of Iressa 2013-2015 (% share)
Exhibit 83: Pfizer: Key highlights
Exhibit 84: Pfizer: Strength assessment
Exhibit 85: Pfizer: Strategy assessment
Exhibit 86: Pfizer: Opportunity assessment
Exhibit 87: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 88: Celgene: Key highlights
Exhibit 89: Celgene: Strength assessment
Exhibit 90: Celgene: Strategy assessment
Exhibit 91: Celgene: Opportunity assessment
Exhibit 92: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場2016-2020：NSCLC、SCLC■ 英文：Global Lung Cancer Therapeutics Market 2016-2020
■ 発行日：2016年11月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10849
■ 調査対象地域：グローバル
- 経腸栄養用機器の世界市場：経腸栄養用ポンプ、経腸栄養用チューブ、セット、注射器The enteral feeding devices market is valued at USD 2.1 Billion in 2016 and is expected to grow at a CAGR of 5.5% during the forecast period of 2016 to 2021. A number of factors such as the growing prevalence of chronic diseases like diabetes, various types of cancers, gastrointestinal diseases, and neurological disorders; rising geriatric population; and growth in the number of preterm births are …
- テレビの未来市場（2025）The TV market is shaken to its very core, profound changes will happen between now and 2025. There will be – and already are– disruptions with important impacts on the audiovisual landscape. Our new prospective report provides a snapshot of the most likely disruptions in TV content distribution up to 2025 as well as in user behaviour. It analyses how the industry’s structure is changing and then p …
- フライアッシュ（セノスフェア）ミクロスフェアの世界市場：種類別（固体、中空粒子）、材料別（フライアッシュ、ガラス、セラミック、金属、高分子）、用途別（石油・ガス、医療技術、塗料・コーティング剤、自動車、建設用複合材料、化粧品・パーソナルケア用品、航空宇宙、ライフサイエンス・バイオテクノロジー）、地域別予測Global Fly Ash (Cenospheres) Microspheres Market to reach USD XXX billion by 2025. Global Fly Ash (Cenospheres) Microspheres Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors predicted to augment the markets are increase in end use industry such as construction, ceramics, autom …
- 脊椎固定装置の世界市場：パイプラインレビュー2015Spinal Fusion - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Spinal Fusion - Pipeline Review, 2015" provides an overview of Spinal Fusion currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipelin …
- 男性美容の世界市場2017-2021ABSTRACTAbout Male Aesthetics One of the aspects of modern life that is considered essential is appearance. The desire to look presentable has led to a notable growth in the cosmetology industry. Cosmetic or aesthetic surgery is evolved from the reconstructive procedure, and hence, some of the techniques are similar whether they are used for reconstructive or cosmetic purposes. For instance, lipos …
- 2014年戦略提言：日本の止血診断市場Complete report $7,400. DataPack (test volumes, sales forecasts, supplier shares) $4,800.SummaryThis comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and techn …
- ラクロス用品の世界市場2017-2021About Lacrosse Equipment Lacrosse is a team sport in which players try to score points by getting a rubber ball into a long lacrosse stick with a net. They run, carry, catch, shoot, and pass the ball with the net of the stick, just to finally reach the goal. Lacrosse has many benefits associated with it in terms of exercise and competitiveness as the game involves a lot of running, speed, and endu …
- 世界の癌診断（検査）市場Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines …
- バルブ及びマニフォールドの世界市場：ボールバルブ、ニードルバルブ、チェックバルブ、リリーフバルブ、マニフォールドAbout the Valves and Manifolds Market Instrumentation valves are devices that are widely used in industrial production processes to control the flow of fluids and gases. The valves can be controlled either physically or automatically. A valve helps to direct, regulate, or control the flow of liquids, gases, fluidized solids, and slurry material through dedicated passageways. There are different ty …
- 世界の無人航空機(UAV)ペイロード市場動向（2012-2016）TechNavio's analysts forecast the Global Unmanned Aerial Vehicle Payload market to grow at a CAGR of 4.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in unmanned aerial vehicle launches. The Global Unmanned Aerial Vehicle Payload market has also been witnessing an increase in R&D. However, the rapid technological changes could pose a …
- 床材の世界市場：材料別（カーペット・ラグ、弾性床材）、非弾性床材別（セラミック、石材、木材、ラミネート）、最終用途別（住宅、非住宅）、地域別予測Global Flooring Market to reach USD 506.6 billion by 2025. Global Flooring Market valued approximately USD 307.6 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2017-2025. Key factors which give growth to the Flooring market are Increase in renovation & remodeling activities, rapid urbanization, and increase in investments in the constru …
- 摩擦攪拌接合（FSW）装置の世界市場2016-2020About Friction Stir Welding Friction stir welding is a technique to join two metals or metal alloys via a solid-state joining process. The process makes use of a third tool that joins the two surfaces. The process involves the generation of heat that softens the surface near the friction stir welding tool. The two pieces of metal are intermixed at the joint, and mechanical pressure is applied by t …
- IB1001 (Hemophilia A and B)：市場予測と分析（～2022）IB1001 (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
- 世界のNoSQL市場動向（2014-2018）TechNavio’s analysts forecast the Global NoSQL market will grow at a CAGR of 53.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased adoption of big data solutions. The Global NoSQL market has also been witnessing increasing demand for skilled professionals. However, the lack of awareness about the potential of NoSQL solutions could pose …
- 世界の飛行乗務員管理システム市場動向（2014-2018）TechNavio's analysts forecast the Global Aviation Crew Management System market to grow at a CAGR of 10.56 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing safety awareness. The Global Aviation Crew Management System market has also been witnessing emerging new scientific fatigue/alertness models. However, the emergence of low-cost vendors …
